Ponoi Management
Latest statistics and disclosures from Ponoi Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RAPT, Ngm Biopharmaceuticals, RVMD, NRIX, and represent 100.00% of Ponoi Management's stock portfolio.
- Ponoi Management has $73M in assets under management (AUM), dropping by 15.64%.
- Central Index Key (CIK): 0001720702
Tip: Access up to 7 years of quarterly data
Positions held by Ponoi Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ponoi Management
Ponoi Management holds 4 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Rapt Therapeutics (RAPT) | 52.5 | $39M | 1.6M | 24.06 |
|
|
| Ngm Biopharmaceuticals | 23.2 | $17M | 1.3M | 13.08 |
|
|
| Revolution Medicines (RVMD) | 18.4 | $14M | 685k | 19.72 |
|
|
| Nurix Therapeutics (NRIX) | 5.8 | $4.3M | 327k | 13.03 |
|
Past Filings by Ponoi Management
SEC 13F filings are viewable for Ponoi Management going back to 2020
- Ponoi Management 2022 Q3 filed Nov. 14, 2022
- Ponoi Management 2022 Q2 filed Aug. 15, 2022
- Ponoi Management 2022 Q1 filed May 16, 2022
- Ponoi Management 2021 Q4 filed Feb. 11, 2022
- Ponoi Management 2021 Q3 filed Nov. 12, 2021
- Ponoi Management 2021 Q2 filed Aug. 16, 2021
- Ponoi Management 2021 Q1 filed May 17, 2021
- Ponoi Management 2020 Q4 filed Feb. 16, 2021